Urist Marshall
Insider CIK 1838139 · RPRX EVP, Research & Investments
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2026-10-05 | 2026-10-05 | 4,126 | $57.10 | $235.6K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-09-28 | 2026-09-30 | 4,126 | $57.88 | $238.8K | 4,126 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-09-28 | 2026-09-30 | 4,126 | $57.88 | $238.8K | 4,126 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2026-08-07 | 2026-08-07 | 3,000 | — | $0 | 244,412 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2026-08-07 | 2026-08-07 | 3,000 | — | $0 | 244,412 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 8,252 | — | $0 | 8,252 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 8,252 | — | $0 | 8,252 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-07-01 | 2026-07-02 | 9,099 | $55.88 | $508.5K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-24 | 2026-06-25 | 9,098 | $55.18 | $502.0K | 9,099 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-05-20 | 2026-05-21 | 13,684 | $52.75 | $721.8K | 18,197 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-05-14 | 2026-05-15 | 13,684 | $53.06 | $726.1K | 31,881 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-05-06 | 2026-05-08 | 18,197 | — | $0 | 45,565 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-02-11 | 2026-02-13 | 19,970 | — | $0 | 27,368 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-30 | 2026-02-02 | 20,000 | $41.09 | $821.8K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-23 | 2026-01-26 | 20,000 | $40.26 | $805.2K | 20,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-16 | 2026-01-20 | 20,000 | $39.52 | $790.4K | 40,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-09 | 2026-01-13 | 20,000 | $40.78 | $815.6K | 60,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-01-02 | 2026-01-06 | 20,000 | $38.48 | $769.6K | 80,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-26 | 2025-12-29 | 20,000 | $39.32 | $786.4K | 100,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-19 | 2025-12-22 | 20,000 | $38.38 | $767.6K | 120,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-16 | 2025-12-17 | 20,000 | $38.32 | $766.4K | 140,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-05 | 2025-12-09 | 18,242 | $39.15 | $714.2K | 7,398 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-05 | 2025-12-09 | 23,334 | $39.15 | $913.5K | 160,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-01 | 2025-12-03 | 23,333 | $39.93 | $931.7K | 183,334 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2025-12-01 | 2025-12-03 | 18,242 | $39.90 | $727.9K | 25,640 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2025-11-07 | 2025-11-07 | 16,000 | — | $0 | 247,412 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2025-11-07 | 2025-11-07 | 160,000 | — | $0 | 206,667 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-11-05 | 2025-11-07 | 4,626 | — | $0 | 43,882 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2025-08-08 | 2025-08-08 | 3,000 | — | $0 | 263,412 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-08-06 | 2025-08-08 | 2,772 | — | $0 | 39,256 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2025-05-16 | 2025-05-20 | 1,356,528 | — | $0 | 1,356,528 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-08 | 2025-05-09 | 36,484 | — | $0 | 83,151 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift deriv | 2024-08-12 | 2024-08-12 | 2,182 | — | $0 | 126,412 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-02-22 | 2023-02-24 | 23,333 | $37.30 | $870.3K | 46,667 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2023-02-17 | 2023-02-17 | 7,000 | — | $0 | 128,594 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2023-02-17 | 2023-02-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-26 | 2022-07-27 | 19,734 | $43.20 | $852.5K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-07-25 | 2022-07-27 | 3,600 | $43.05 | $155.0K | 19,734 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-06-24 | 2022-06-24 | 23,333 | $43.19 | $1.01M | 23,334 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-05-16 | 2022-05-16 | 23,333 | $39.85 | $929.8K | 46,667 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2022-05-11 | 2022-05-11 | 7,000 | — | $0 | 205,594 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2022-05-11 | 2022-05-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-07 | 2021-06-08 | 16,568 | $47.02 | $779.0K | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-04 | 2021-06-08 | 16,566 | $45.13 | $747.6K | 16,568 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-06-02 | 2021-06-04 | 14,566 | $41.52 | $604.8K | 33,134 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-05-21 | 2021-05-24 | 100 | $41.00 | $4.1K | 47,700 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2021-05-20 | 2021-05-24 | 1,900 | $41.08 | $78.1K | 47,800 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2021-05-07 | 2021-05-11 | 4,970 | — | $0 | 142,594 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2021-05-07 | 2021-05-11 | 49,700 | — | $0 | 49,700 | SEC↗ |